Optimal Blood Management in Elective Orthopaedic Surgery: The Transfusion "Op Maat" (TOMaat) Study.

Trial Profile

Optimal Blood Management in Elective Orthopaedic Surgery: The Transfusion "Op Maat" (TOMaat) Study.

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 May 2012

At a glance

  • Drugs Recombinant erythropoietin (Primary)
  • Indications Perioperative haemorrhage
  • Focus Therapeutic Use
  • Acronyms TOMaat
  • Most Recent Events

    • 08 May 2012 Planned patient number is 2250 according to Netherlands Trial Register.
    • 08 May 2012 New source identified and integrated (Netherlands Trial Register; NTR303).
    • 02 Nov 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top